High shock impedance during subcutaneous implantable defibrillator generator replacements: Authors' reply

Affiliations

¹ Department of Clinical and Experimental Cardiology, Amsterdam UMC, Location AMC, Room C0-333, PO Box 22700, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands.

Comment

Willeke van der Stuijt et al. Europace. 2022.

. 2022 Feb 2;24(2):350-351.

doi: 10.1093/europace/euab205.

¹ Department of Clinical and Experimental Cardiology, Amsterdam UMC, Location AMC, Room C0-333, PO Box 22700, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands.

No abstract available

Comment on

Complications related to elective generator replacement of the subcutaneous implantable defibrillator.
van der Stuijt W, Quast ABE, Baalman SWE, de Wilde KC, Brouwer TF, Wilde AAM, Knops RE. van der Stuijt W, et al. Europace. 2021 Mar 8;23(3):395-399. doi: 10.1093/europace/euaa263. Europace. 2021. PMID: 33197266 Free PMC article.
High shock impedance during subcutaneous implantable defibrillator generator replacements.
Maass AH, Groenveld HF, Mulder BA, Blaauw Y, Rienstra M. Maass AH, et al. Europace. 2022 Feb 2;24(2):349-350. doi: 10.1093/europace/euab203. Europace. 2022. PMID: 34626189 No abstract available.

1. Maass AH, Groenveld HF, Mulder BA, Blaauw Y, Rienstra M. High shock impedance during subcutaneous implantable defibrillator generator replacements. Europace 2022;24:349--50. - PubMed
1. Van Der Stuijt W, , QuastE, , BaalmanSWE, , De WildeKC, , BrouwerTF, , Wilde AAM et al. . . Complications related to elective generator replacement of the subcutaneous implantable defibrillator. Europace 2021;23:395–9. - PMC - PubMed
1. Boersma L, Barr C, Knops R, Theuns D, Eckardt L, Neuzil P et al.; EFFORTLESS Investigator Group. Implant and midterm outcomes of the subcutaneous implantable cardioverter-defibrillator registry: the EFFORTLESS study. J Am Coll Cardiol 2017;70:830–41. - PubMed
1. Healey JS, Hohnloser SH, Glikson M, Neuzner J, Mabo P, Vinolas X et al. Cardioverter defibrillator implantation without induction of ventricular fibrillation: a single-blind, non-inferiority, randomised controlled trial (SIMPLE). Lancet 2015;385: 785–91. - PubMed
1. Quast A-FBE, Baalman SWE, Brouwer TF, Smeding L, Wilde AAM, Burke MC et al. A novel tool to evaluate the implant position and predict defibrillation success of the subcutaneous implantable cardioverter-defibrillator: the PRAETORIAN score. Heart Rhythm 2019;16:403–10. - PubMed